Table 1.
Relationship between Cbl-b Expression and the Clinical Pathological Parameters in MDR Gastric Cancer Patients
| Clinical Pathological Parameters | Number | Gastric Cancer |
P | |
|---|---|---|---|---|
| Cbl-b Positive (n = 68) | Cbl-b Negative (n = 38) | |||
| Age (years) | ||||
| ≤60 | 48 | 34 | 14 | |
| >60 | 58 | 34 | 24 | .192⁎ |
| Sex | ||||
| Male | 60 | 36 | 24 | |
| Female | 46 | 32 | 14 | .309⁎ |
| Differentiation | ||||
| Well/moderate | 40 | 28 | 12 | |
| Poor | 66 | 40 | 26 | .328⁎ |
| Depth of invasion | ||||
| T1 + T2 | 32 | 26 | 6 | |
| T3 + T4 | 74 | 42 | 32 | .016⁎ |
| LN metastasis | ||||
| No | 34 | 28 | 6 | |
| Yes | 72 | 40 | 32 | .007⁎ |
| TNM stage | ||||
| I + II | 37 | 30 | 7 | |
| III + IV | 69 | 38 | 31 | .008⁎ |
LN, lymph node.
Two-sided P value; values shown in bold were statistically significant.
⁎
Chi-squared test.